Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection - Bryce M. Warner; Robert Vendramelli; Amrit S. Boese; Jonathan Audet; Nikesh Tailor; Courtney Meilleur; Nathan Glowach; Marnie Willman; Thang Truong; Estella Moffat; Kevin Tierney; Beata Kosak; et al. (PLoS ONE, 2025)